Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013.

about

Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013.

Item

http://www.wikidata.org/entity/Q35903489

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Guidelines for menopausal horm ...... knowledge as of December 2013.

@ast

Guidelines for menopausal horm ...... knowledge as of December 2013.

@en

type

Item

label

Guidelines for menopausal horm ...... knowledge as of December 2013.

@ast

Guidelines for menopausal horm ...... knowledge as of December 2013.

@en

prefLabel

Guidelines for menopausal horm ...... knowledge as of December 2013.

@ast

Guidelines for menopausal horm ...... knowledge as of December 2013.

@en

P1476

Guidelines for menopausal horm ...... knowledge as of December 2013.

@en

P2093

Magdalena Sendrakowska

http://www.w3.org/2001/XMLSchema#string

Małgorzata Bińkowska

http://www.w3.org/2001/XMLSchema#string

Romuald Dębski

http://www.w3.org/2001/XMLSchema#string

Tomasz Paszkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.

The 2012 hormone therapy position statement of: The North American Menopause Society.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/PM.2014.41078

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wojciech Zgliczyński

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271071366

http://www.w3.org/2001/XMLSchema#string

P698

26327821

http://www.w3.org/2001/XMLSchema#string

P932

4520330

http://www.w3.org/2001/XMLSchema#string